Sector footprint
$11.0M in exports
Reported chemicals exports in 2024 across 33 qualifying HS6 products.
Sector export playbook ยท HS 28-38
Venezuela Chemicals exports
where capability meets demand
Explore Venezuela's HS 28-38 product portfolio, buyer markets, growth signals, and diversification opportunities. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Sector exports$11.0M2024 reported value
Products33Qualifying HS6 products
Buyer markets20Markets represented
Average CAGR-8.1%Product-level growth signal
Global sector size$431.4BReported buyer imports
Chemicals capability
How strong is Venezuela in this sector?
Compare exporter scale with product breadth, buyer demand, growth, and destination reach. A large sector does not remove the need for product, compliance, pricing, and buyer validation.
Global demand
$431.4B buyer imports
The sector's reported buyer import base provides context for product and market prioritization.
How to use the guide
Find the next credible move
Start with products that combine demand and exporter capability, then validate standards, route economics, buyers, and competition.
Product portfolio
Which products anchor the sector?
Each HS6 product is ranked by calculated opportunity and shown with reported market size, exporter exports, growth, and destination reach.
| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
|---|---|---|---|---|---|---|
| HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $258.4B | $1.3M | $94.4B | -7.3% | 16 | +0.0% |
| HS 382499Chemical products, mixtures and preparations: n.e.c. heading 3824 | $24.8B | $78.1K | $15.8B | -26.3% | 8 | +0.0% |
| HS 300212Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $18.4B | $20.8K | $10.4B | +13.7% | 4 | +0.0% |
| HS 330210Odoriferous substances and mixtures: of a kind used in the food or drink industries | $6.8B | $5.5K | $9.6B | -3.6% | 2 | +0.0% |
| HS 300220Vaccines: for human medicine | $8.4B | $5.6K | $8.8B | +98.4% | 2 | +0.0% |
| HS 293359Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $8.3B | $20.1K | $8.5B | -65.2% | 1 | +0.0% |
| HS 300439Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $15.1B | $8.1K | $7.8B | +18.4% | 4 | +0.0% |
| HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $16.3B | $2.2K | $6.9B | -3.2% | 3 | +0.0% |
| HS 293499Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $7.2B | $2.8K | $5.7B | -8.0% | 2 | +0.0% |
| HS 293399Heterocyclic compounds: n.e.c. in headings no. 2933 | $6.9B | $21.9K | $5.0B | +22.4% | 1 | +0.0% |
| HS 330300Perfumes and toilet waters | $8.5B | $16.8K | $5.0B | -12.8% | 3 | +0.0% |
| HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $12.4B | $1.8K | $4.6B | -18.8% | 3 | +0.0% |
| HS 281820Aluminium oxide: other than artificial corundum | $5.7B | $5.4M | $3.9B | -13.7% | 3 | +0.3% |
| HS 300390Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $8.3K | $2.2B | -14.8% | 2 | +0.0% |
| HS 290919Ethers: acyclic, and their halogenated, sulphonated, nitrated or nitrosated derivatives, other than diethyl ether | $1.5B | $312.6 | $2.1B | -36.2% | 1 | +0.0% |
| HS 300420Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $110.6 | $2.0B | -30.0% | 1 | +0.0% |
| HS 382319Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $146.9K | $1.9B | +16.9% | 1 | +0.0% |
| HS 310420Fertilizers, mineral or chemical: potassic, potassium chloride | $3.6B | $5.8K | $1.8B | -10.8% | 1 | +0.0% |
| HS 284190Salts of oxometallic or peroxometallic acids: n.e.c. in heading no. 2841 | $1.7B | $3.5K | $1.7B | -18.3% | 1 | +0.0% |
| HS 381512Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $1.4B | $25.2 | $1.7B | -31.5% | 1 | +0.0% |
| HS 293590Sulphonamides: n.e.c. in heading no. 2935 | $1.1B | $2.2 | $1.4B | -38.3% | 1 | +0.0% |
| HS 300670Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $2.7K | $1.4B | -12.6% | 1 | +0.0% |
| HS 284410Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | $1.6B | $14.7K | $1.4B | +10.9% | 1 | +0.0% |
| HS 291736Acids: aromatic polycarboxylic acids: terephthalic acid and its salts | $1.6B | $267.7K | $1.4B | -55.5% | 1 | +0.0% |
| HS 310221Fertilizers, mineral or chemical: nitrogenous, ammonium sulphate | $965.4M | $1.7M | $1.3B | +69.7% | 1 | +0.6% |
| HS 290110Acyclic hydrocarbons: saturated | $916.4M | $885.3K | $1.3B | -5.3% | 1 | +0.3% |
| HS 290250Cyclic hydrocarbons: styrene | $768.8M | $340.1 | $1.1B | -91.2% | 1 | +0.0% |
| HS 300290Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $10.4 | $1.0B | -25.2% | 1 | +0.0% |
| HS 310559Fertilizers, mineral or chemical: containing the two fertilizing elements nitrogen and phosphorus, other than nitrates and phosphates | $1.2B | $439.7K | $961.6M | +15.2% | 1 | +0.1% |
| HS 290220Cyclic hydrocarbons: benzene | $1.4B | $683.8K | $894.4M | -9.3% | 1 | +0.1% |
| HS 300449Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale | $1.5B | $16.9K | $841.5M | +14.2% | 1 | +0.0% |
| HS 290243Cyclic hydrocarbons: p-xylene | $820.5M | $281.7 | $838.8M | -91.2% | 1 | +0.0% |
| HS 330290Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $36.7 | $803.3M | -15.3% | 1 | +0.0% |
Best markets
Where does sector demand concentrate?
Markets are ranked by calculated opportunity across the qualifying products in this sector view.
USA
USA, Puerto Rico and US Virgin Islands
16 products represented in the sector.
$58.4B$138.5B reported buyer importsCHE
Switzerland, Liechtenstein
2 products represented in the sector.
$31.0B$46.5B reported buyer importsDEU
Germany
7 products represented in the sector.
$17.8B$50.9B reported buyer importsBEL
Belgium
3 products represented in the sector.
$16.1B$27.1B reported buyer importsMEX
Mexico
7 products represented in the sector.
$12.6B$12.8B reported buyer importsESP
Spain
6 products represented in the sector.
$11.2B$18.9B reported buyer importsITA
Italy
3 products represented in the sector.
$10.7B$23.0B reported buyer importsCHN
China
3 products represented in the sector.
$9.0B$16.8B reported buyer importsCAN
Canada
4 products represented in the sector.
$8.0B$12.7B reported buyer importsNLD
Netherlands
2 products represented in the sector.
$6.7B$11.7B reported buyer importsBRA
Brazil
5 products represented in the sector.
$6.6B$11.3B reported buyer importsGBR
United Kingdom
2 products represented in the sector.
$6.1B$16.6B reported buyer importsGrowth stars
Which products show the strongest growth?
Average product-level CAGR is a screening signal. Confirm the latest trend, base effects, buyer quality, and commercial feasibility before acting.
| Product | Average CAGR | Opportunity | Markets |
|---|---|---|---|
| HS 300220Vaccines: for human medicine | +98.4% | $8.8B | 2 |
| HS 310221Fertilizers, mineral or chemical: nitrogenous, ammonium sulphate | +69.7% | $1.3B | 1 |
| HS 293399Heterocyclic compounds: n.e.c. in headings no. 2933 | +22.4% | $5.0B | 1 |
| HS 300439Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | +18.4% | $7.8B | 4 |
| HS 382319Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | +16.9% | $1.9B | 1 |
| HS 310559Fertilizers, mineral or chemical: containing the two fertilizing elements nitrogen and phosphorus, other than nitrates and phosphates | +15.2% | $961.6M | 1 |
| HS 300449Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale | +14.2% | $841.5M | 1 |
| HS 300212Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | +13.7% | $10.4B | 4 |
| HS 284410Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | +10.9% | $1.4B | 1 |
| HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | -3.2% | $6.9B | 3 |
Diversification opportunities
Which products reach the widest buyer base?
Destination count is a simple breadth indicator. It does not measure destination concentration or guarantee resilience.
HS 300490
Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
16 markets$94.4B calculated opportunityHS 382499
Chemical products, mixtures and preparations: n.e.c. heading 3824
8 markets$15.8B calculated opportunityHS 300212
Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions
4 markets$10.4B calculated opportunityHS 300439
Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale
4 markets$7.8B calculated opportunityHS 330499
Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations)
3 markets$6.9B calculated opportunityHS 330300
Perfumes and toilet waters
3 markets$5.0B calculated opportunityHS 382200
Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material
3 markets$4.6B calculated opportunityHS 281820
Aluminium oxide: other than artificial corundum
3 markets$3.9B calculated opportunityFrequently asked questions
Using the Chemicals export playbook
Practical guidance for interpreting sector scale, growth, product breadth, and buyer markets.
How strong is Venezuela in this sector?
Compare sector exports, product breadth, buyer markets, growth, and global demand. These signals identify research priorities rather than guarantee market access.
What are growth stars?
Products with higher average reported growth in the screened rows. Validate the time period, base effects, buyer demand, and current exporter position.
What does diversification mean here?
Products reaching more buyer markets in the screened data. Destination breadth is useful context but does not replace concentration, route, or buyer analysis.
Data source
OECD trade statistics with CEPII context
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.